Keisuke Shigeta

10PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiological physicsCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

|Jul 07, 2023
Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy.

Takahiro Komori, Kazuhiro Matsumoto, Takeo Kosaka

|Jan 13, 2023
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.

Keisuke Shigeta, Masanori Hasegawa, Takako Hishiki

|Dec 28, 2020
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.

Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara

Pageof 2